Dame Emma Walmsley
Chief Executive Officer
Emma Walmsley - download image (JPG)
Emma was appointed to the Board as Chief Executive Officer Designate on 1 January 2017 and became Chief Executive Officer on 1 April 2017. She is a member of the Corporate Executive Team.
Skills and experience
Prior to her appointment as GSK’s CEO, Emma was the CEO of GSK Consumer Healthcare, a Joint Venture between GSK and Novartis, from its creation in March 2015, and has been a member of GSK’s Corporate Executive Team since 2011. Emma joined GSK in 2010 with responsibility for Consumer Healthcare Europe. Before joining GSK in 2010, Emma worked with L’Oreal for 17 years in a variety of marketing and general management roles in Paris, London and New York. From 2007 she was based in Shanghai as General Manager, Consumer Products for L’Oreal China. Emma was previously a Non-Executive Director of Diageo plc from January to September 2016.
Emma was appointed Dame (DBE) for services to the pharmaceutical industry and business in the 2020 British Honours.
Emma holds an MA in Classics and Modern Languages from Oxford University.
External appointments
- Independent Director, Microsoft, Inc
- Honorary Fellow, Royal Society of Chemistry
Find out more
-
Speeches & presentations
Search through our archive of speeches and presentations from conferences and events
-
Quarterly results
Discover our latest financial performance announcement and search for historical quarterly results materials
-
Board of Directors
The Board of Directors is responsible for the group's system of corporate governance and is ultimately accountable for the group's activities, strategy, risk management and financial performance.
-
Corporate Executive Team
The Corporate Executive Team manages our activities, and each member is responsible for a specific part of the business
